A

Angstrom Pharmaceuticals Inc

10 employees

Angstrom Pharmaceuticals develops new class of drugs targeting CD44 for the treatment of metastatic diseases and hematological malignancies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Clinical Trials

Date founded

1996

Funding rounds raised

A

Angstrom Pharmaceuticals Inc raised undisclosed on September 1, 2003

Investors: -

FAQ